Inspira Technologies OXY BHN Ltd., a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, today announces the closing of its previously announced registered direct offering of 3,031,250 ordinary shares (or ordinary share equivalents in lieu thereof), at a purchase price of $1.28 per ordinary share (or ordinary share equivalents in lieu thereof). Inspira has also issued in a private placement warrants to purchase up to an aggregate of 3,031,250 ordinary shares at an exercise price of $1.28 per share. The warrants are exercisable immediately upon issuance on the closing date and will expire on the date that is three and one-half half year after the closing date. The aggregate gross proceeds from the offering were approximately $3.88 million, before deducting placement agent fees and other estimated offering expenses.

 

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.